New Mountain Capital Plants Flag in Seoul with New Office

New Mountain Capital, the New York-based private equity firm managing over $50 billion, opened a Seoul office this week — its fourth location in Asia and a signal that South Korea's maturing private markets are finally commanding serious attention from Western capital.

The firm isn't just planting a flag. It's staffing up with local talent and targeting two sectors where Korea punches above its weight: enterprise software and specialized healthcare services. Both happen to be New Mountain's bread and butter in North America, where it's built a two-decade track record backing founder-led companies in defensive growth markets.

What makes this move notable isn't novelty — plenty of U.S. firms have Asia outposts. It's timing. South Korea's private equity market hit $18 billion in deal volume last year, up 40% from 2024, driven by founder exits in the tech sector and regulatory changes that finally make buyouts less painful. New Mountain is arriving just as the market's getting interesting.

The Seoul office will be led by managing director James Park, who joined New Mountain in 2023 after stints at Goldman Sachs and local firm IMM Private Equity. Park brings relationships across Korea's chaebol-adjacent tech ecosystem — the layer of mid-sized software and services companies that supply Samsung, LG, and Hyundai but operate independently enough to accept outside capital.

South Korea's private equity landscape has historically been dominated by local players and a handful of regional firms. Foreign capital faced structural headwinds: family-controlled companies resistant to selling, limited exit routes beyond IPOs, and labor laws that made operational restructuring difficult.

That's changing. Korea revised its commercial code in 2024 to ease majority ownership transfers, and the Korea Exchange introduced a fast-track IPO process for PE-backed companies last year. Exits that once took 7-9 years are now happening in 4-5. That matters when LPs are demanding liquidity.

More importantly, a generation of tech founders who built companies in the 2010s are now in their 50s and 60s, looking for liquidity events. Many bootstrapped their way to $50-200 million in revenue without venture capital, creating exactly the kind of profitable, capital-efficient businesses New Mountain likes to buy.

"Korea has a deep bench of B2B software companies that are unknown outside the region but generate strong cash flow and have real moats in vertical markets," said Sarah Kim, a Seoul-based partner at advisory firm MVision. "The founders are finally open to selling, and the buyers are showing up."

The Seoul office joins existing New Mountain locations in Hong Kong, Singapore, and Mumbai. Each serves a different function. Hong Kong handles Greater China investments. Singapore covers Southeast Asia and acts as the regional headquarters. Mumbai focuses on India's software services and healthcare IT sectors.

Seoul will operate semi-independently, sourcing and executing deals in South Korea with support from the Singapore office on structuring and exits. The firm declined to specify headcount targets but said it plans to hire at least three additional investment professionals locally by year-end.

New Mountain has closed two deals in Korea over the past 18 months without a local office — a minority stake in healthcare IT platform MediBloc in late 2024 and a majority buyout of enterprise collaboration software maker Flexday in early 2025. Both remain under the radar but fit the firm's thesis: recurring revenue models, strong unit economics, and leadership teams that stay post-transaction.

The Flexday deal is instructive. It's a $90 million revenue SaaS company serving mid-sized Korean manufacturers with workflow automation tools. Founder and CEO David Choi retained 30% equity and continues to run the business. New Mountain brought in a CFO, upgraded the sales team, and is funding expansion into Japan and Taiwan. Classic growth equity playbook, but applied to a bootstrapped Korean founder who'd never taken outside capital before.

Source: Korea Private Equity & Venture Capital Association, Preqin, MVision analysis

Software deals accounted for 29% of Korea's private equity volume last year, up from 18% in 2023. Healthcare services — clinics, diagnostics, specialty care networks — made up another 22%. Together, those two sectors represent just over half of all PE capital deployed in the country.

New Mountain's strategy in Asia mirrors what it does in the U.S. and Europe: find companies in non-cyclical sectors with high switching costs, buy them at reasonable multiples (typically 8-12x EBITDA), then grow them through a mix of organic investment and strategic M&A.

In Korea, that translates to a specific profile. The firm is targeting B2B software companies with $50-150 million in revenue, serving vertical markets like manufacturing, logistics, or financial services. On the healthcare side, it's looking at specialized service providers — think dialysis clinic networks, medical imaging chains, or healthcare IT platforms that handle everything from billing to patient records.

These aren't sexy businesses. They're boring, cash-generative, and deeply embedded in their customers' operations. Exactly what New Mountain wants.

The firm is also explicit about what it won't touch: early-stage venture deals, consumer-facing apps, anything that requires multiple rounds of future funding, and businesses where regulatory risk is the primary driver of returns. That rules out most of Korea's high-flying unicorn wannabes.

"We're not competing with venture funds for the next Coupang," Park said in a statement. "We're looking for companies that have already figured out product-market fit and need capital to scale operations, enter new markets, or consolidate fragmented industries."

One wrinkle: Korea's economy is still dominated by the chaebols — family-controlled conglomerates like Samsung, Hyundai, and SK Group. They cast a long shadow over every sector they touch, often as customers, competitors, or both.

New Mountain's targets typically sit adjacent to the chaebols rather than competing directly. A logistics software company might serve Hyundai's supplier network without threatening Hyundai's own IT operations. A healthcare clinic chain might treat Samsung employees through corporate wellness contracts without challenging Samsung's hospital investments. The trick is finding businesses with enough independence to grow but enough proximity to benefit from chaebol spending.

New Mountain isn't alone in eyeing Korea. KKR opened a Seoul office in 2023. Bain Capital has been active in the market since 2021. MBK Partners, a regional firm with deep Korea expertise, raised a $6.5 billion fund last year and is aggressively buying mid-market tech companies.

The influx of foreign capital is pushing up valuations. Software companies that traded at 6-8x EBITDA three years ago now fetch 10-14x in competitive auctions. Healthcare assets are even pricier, with specialty clinic networks going for 12-16x.

That's creating a tension. PE firms want the growth and structural advantages of the Korean market, but they also want discipline on entry multiples. Something has to give. Either valuations moderate as more assets come to market, or firms start walking away from deals that don't pencil out at current prices.

New Mountain has a reputation for walking. The firm passed on over 300 deals globally last year and closed just 11. "We're not under pressure to deploy capital quickly," said co-president Adam Weinstein in a February earnings call. "If the price isn't right, we wait."

The other question is exits. Korea's IPO market is improving but still shallow compared to the U.S. or even China. Only 14 PE-backed companies went public on the Korea Exchange last year, and median post-IPO liquidity was limited — many stocks trade thinly after the first few months.

That leaves secondary sales as the primary exit route. In 2025, 68% of Korean PE exits were sales to other PE firms or strategic buyers. New Mountain will likely need to rely on the same playbook: buy, grow, and sell to the next buyer in 4-6 years.

For New Mountain, the Seoul office is a long-term bet. The firm doesn't need to do 10 deals a year in Korea to justify the investment. Three to five high-quality buyouts over the next 24 months would be a win — especially if they generate the kind of steady, compounding returns the firm is known for.

The real test will be whether New Mountain can replicate its North American playbook in a market with different cultural norms, tighter labor markets, and less-developed service ecosystems. Bringing in a new CFO is easy in New York. In Seoul, the talent pool for PE-grade finance executives is smaller, and poaching from the chaebols comes with complications.

Park's hire suggests the firm understands this. He's not a parachuted-in expat running a regional office from afar. He's a Korean national with local relationships and an understanding of how business actually gets done in Seoul — which often involves dinners, introductions, and trust-building that can't be shortcut by writing a bigger check.

If New Mountain can crack that code, Korea could become a meaningful contributor to returns over the next decade. If it can't, the Seoul office will be a modest cost center that sources the occasional deal but never scales into a core market. Given the firm's track record and disciplined approach, the former seems more likely than the latter.

The table below shows the major private equity firms active in South Korea, their local presence, and recent notable deals. New Mountain enters a market that's more crowded than it was five years ago but still less saturated than Japan or China.

Source: Company announcements, Preqin, press reports

MBK Partners remains the dominant player with over $28 billion under management and a 20-year head start. But the firm's portfolio skews toward larger deals and traditional industries. New Mountain's focus on capital-efficient software and healthcare services puts it in a different lane — one with less direct competition and potentially higher growth.

A few things remain unclear. New Mountain hasn't disclosed the size of its Korea allocation or whether it's raising a dedicated Asia fund. The firm's flagship funds are global vehicles, so Korea deals could come from general capital pools rather than a ring-fenced strategy.

It's also uncertain how much operational support the Seoul office will provide post-acquisition. New Mountain's North American portfolio companies get access to a network of operating partners, specialized recruiters, and industry experts. Replicating that in Korea will require building a local ecosystem — or relying more heavily on Singapore-based resources.

And then there's the political backdrop. U.S.-China tensions have made cross-border deals more complicated, and while Korea isn't China, it's geographically and economically tied to the region in ways that could create friction. Export controls, data localization rules, and supply chain restrictions all create potential complications for PE-backed companies with regional operations.

New Mountain is betting those risks are manageable. Time will tell if the firm's Seoul office becomes a meaningful part of its Asia strategy or just another pin on the map.

The real indicator of success won't be the office opening itself. It'll be the deals. If New Mountain closes three to four transactions in Korea over the next 18 months, the Seoul office is working. If it announces a dedicated Asia fund with a Korea mandate, that's a stronger signal. If it hires a senior operating partner locally, that suggests it's building for the long term.

Also watch whether other mid-market U.S. firms follow. New Mountain's move could be a leading indicator that Korea's private equity market is finally ready for sustained foreign capital inflows — or it could be an outlier bet that doesn't pan out. The next 12 months will clarify which.

For now, Korea has another name-brand PE firm on the ground. Whether that translates into actual deployed capital is the question that matters.

The firm declined to comment on specific investment targets or capital commitments for the Seoul office beyond what was included in its public announcement. That's typical New Mountain — execute quietly, announce selectively, and let the returns speak later.